Company news
Zelira Therapeutics Ltd. news in 2017
Zelira Therapeutics Ltd.'s news releases, calls and decks from 2017, newest first.
Zelda joins with US Childrens Hospital for autism study
December 10, 2017
Australian Regulators Approve Zelda Insomnia Clinical Trial
November 28, 2017
Successful Results in Autism Observation Trial
September 17, 2017
Expansion of Breast Cancer Research Collaboration
July 31, 2017
Zelda Enters into Strategic Agreement with Knop Laboratories
June 14, 2017
Positive Results From Pre-Clinical Breast Cancer Studies
June 1, 2017
March 2017 Quarterly Report
April 28, 2017
Clinical Research Programme to Expand to Include Autism
April 18, 2017
Cleansing Prospectus
April 3, 2017
Zelda Successfully Completes Capital Raising
March 29, 2017
Zelda Enters Strategic Partnership with CannPal
March 26, 2017
Clinical Trials to Commence in Chile
March 22, 2017
New Licence Agreement
March 21, 2017
Appendix 4D & FY17 Interim Financial Report
February 27, 2017
Quarterly Report and Appendix 4C
January 31, 2017
Decks in 2017
- Zelda Therapeutics — Shareholder Meeting (November 2017)
Shareholder meeting · 24 slides · Nov 24, 2017
- Zelda Therapeutics — Investor Presentation (February 2017)
Investor deck · 23 slides · Feb 8, 2017